Sanofi India Q2 profit rises 33% to Rs85 crore
Standalone total income from operations of Sanofi India rose to Rs608 crore in June quarter as against Rs549.7 crore in the year-ago period
New Delhi: Drug firm Sanofi India Ltd on Friday reported a 32.86% rise in standalone net profit to ₹ 85.3 crore for the second quarter ended 30 June 2016.
The company had reported had posted a net profit of ₹ 64.2 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
Standalone total income from operations of the company also rose to ₹ 608 crore for the quarter under consideration as against ₹ 549.7 crore for the same period year ago.
In a separate filing, the company, which follows January-December as its fiscal, said it’s board of directors has declared an interim dividend of ₹ 18 per equity share of ₹ 10 each.
Shares of the company on Friday closed 0.32% down at ₹ 4,500.05 a scrip on BSE.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!